Lansforsakringar Fondforvaltning’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.39M Sell
62,564
-2
-0% -$175 0.02% 438
2026
Q1
$5.66M Buy
62,566
+280
+0.4% +$25.7K 0.03% 370
2025
Q4
$5.6M Buy
62,286
+600
+1% +$56.9K 0.03% 386
2025
Q3
$6.08M Buy
61,686
+402
+0.7% +$39.8K 0.03% 372
2025
Q2
$5.59M Sell
61,284
-6,162
-9% -$596K 0.03% 372
2025
Q1
$7.63M Sell
67,446
-772
-1% -$82.6K 0.05% 317
2024
Q4
$7.21M Buy
+68,218
New +$7.32M 0.04% 334

Other funds holding ZBH

Lansforsakringar Fondforvaltning's ZBH Position: Q2 2026 in Review

Lansforsakringar Fondforvaltning reduced its Zimmer Biomet (ZBH) stake by 0% in Q2 2026, selling an estimated $175 and leaving 62,564 shares worth $5.39M. The position accounts for 0.02% of the portfolio, ranked #438.

Lansforsakringar Fondforvaltning first reported a position in ZBH in Q4 2024 and has held it in 7 quarters since. The position peaked at $7.63M in Q1 2025. 912 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Lansforsakringar Fondforvaltning held 62,564 shares of Zimmer Biomet worth $5.39M as of Q2 2026.
  • Lansforsakringar Fondforvaltning sold 2 Zimmer Biomet shares in Q2 2026, an estimated $175.
  • Zimmer Biomet made up 0.02% of Lansforsakringar Fondforvaltning's portfolio in Q2 2026, its #438 holding.
  • Lansforsakringar Fondforvaltning first reported a position in Zimmer Biomet in Q4 2024 and has held it in 7 quarters since.
  • Lansforsakringar Fondforvaltning's Zimmer Biomet position peaked at $7.63M in Q1 2025.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Lansforsakringar Fondforvaltning's 13F filing for Q2 2026, filed 13 Aug 2026.